CD4 and thyroid nodule: Using the independent predictors identified by LASSO regression (age, BRAFV600E genotype, NK cell counts, NK cell percentages, and CD4+ T cell percentages), we constructed a clinically applicable nomogram (Figure 2) to estimate the individualized risk of malignancy in thyroid nodules classified as C-TIRADS category 3 or above.